KRAS is a gatekeeper gene in colorectal tumorigenesis as well as pancreatic ductal adenocarcinoma (PDAC) and non-small-cell lung cancer (NSCLC) and is thus an attractive target [11]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.